Do Myoepithelial Cells Hold the Key for Breast Tumor Progression?

AbstractMammary myoepithelial cells have been a neglected facet of breast cancer biology, largely ignored since they have been considered to be less important for tumorigenesis than luminal epithelial cells from which most of breast carcinomas are thought to arise. In recent years as our knowledge of stem cell biology and the cellular microenvironment has been increasing, myoepithelial cells are slowly starting to gain more attention. Emerging data raise the hypothesis whether myoepithelial cells play a key role in breast tumor progression by regulating the in situ to invasive carcinoma transition and that myoepithelial cells are part of the mammary stem cell niche. Paracrine interactions between myoepithelial and luminal epithelial cells are known to be important for regulation of cell cycle progression, establishing epithelial cell polarity, and inhibiting cell migration and invasion. Based on these functions, normal mammary myoepithelial cells have been called “natural tumor suppressors.” However, during tumor progression myoepithelial cells seem to loose these properties, and eventually this cell population diminishes as tumors become invasive. Better understanding of myoepithelial cell function and their role in tumor progression may lead to their exploitation for cancer therapeutic and preventative measures.

[1]  P. Quesenberry,et al.  Stem Cells and Prenatal Origin of Breast Cancer , 2004, Cancer Causes & Control.

[2]  M. Stratton,et al.  Genetic alterations in ‘normal’ luminal and myoepithelial cells of the breast , 1999, The Journal of pathology.

[3]  S. Devries,et al.  Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. , 2000, Journal of the National Cancer Institute.

[4]  T. Ratliff TGF-Beta Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004 .

[5]  F. Miller,et al.  Multipotent human breast stem cell line MCF1OAT. , 1996, International journal of oncology.

[6]  Yudong D. He,et al.  Expression profiling predicts outcome in breast cancer , 2002, Breast Cancer Research.

[7]  Garrison Fh,et al.  [History of cancer]. , 1926, Il Policlinico. Sezione pratica.

[8]  Rameen Beroukhim,et al.  Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.

[9]  Å. Borg,et al.  Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors , 2005, Modern Pathology.

[10]  T. Tlsty,et al.  Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.

[11]  Sanford H Barsky,et al.  Human breast carcinoma desmoplasia is PDGF initiated , 2000, Oncogene.

[12]  H. Höfler,et al.  Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: Evidence of genetic resemblance by CGH , 2000, International journal of cancer.

[13]  B. Unsworth,et al.  Embryonic inductive tissues that cause histologic differentiation of murine mammary carcinoma in vitro. , 1975, Journal of the National Cancer Institute.

[14]  S. Barsky,et al.  The human myoepithelial cell displays a multifaceted anti-angiogenic phenotype , 2000, Oncogene.

[15]  G. Bratthauer,et al.  Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. , 2000, Cancer research.

[16]  A. Gown,et al.  Detection of Stromal Invasion in Breast Cancer: The Myoepithelial Markers , 2000, Advances in anatomic pathology.

[17]  R. D'Amato,et al.  Genetic heterogeneity of angiogenesis in mice , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  D. Stoppa-Lyonnet,et al.  High-risk lesions in high-risk women: a high-risk formalin-based biology! , 2004, Journal of Clinical Oncology.

[19]  G. Viale,et al.  p63, a p53 Homologue, Is a Selective Nuclear Marker of Myoepithelial Cells of the Human Breast , 2001, The American journal of surgical pathology.

[20]  T. Calcaterra,et al.  Establishment and characterization of a novel human myoepithelial cell line and matrix-producing xenograft from a parotid basal cell adenocarcinoma , 1996, In Vitro Cellular & Developmental Biology - Animal.

[21]  A. Feinberg,et al.  The history of cancer epigenetics , 2004, Nature Reviews Cancer.

[22]  J. Tobacman,et al.  Steroid sulfatase activity and expression in mammary myoepithelial cells , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  G. Dontu,et al.  Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells , 2004, Breast Cancer Research.

[24]  N. Bundred,et al.  Molecular markers and therapeutic targets in ductal carcinoma in situ , 2002, Microscopy research and technique.

[25]  H. Thornton,et al.  Ductal carcinoma-in-situ of the breast , 1992, The Lancet.

[26]  B. Gusterson,et al.  Breast development gives insights into breast disease , 1998, Histopathology.

[27]  E. Lane,et al.  The development of epithelial phenotypes in the human fetal and infant breast , 1998, The Journal of pathology.

[28]  G. Bratthauer,et al.  A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers , 2003, Breast Cancer Research.

[29]  J. Russo,et al.  Atlas and Histologic Classification of Tumors of the Rat Mammary Gland , 2000, Journal of Mammary Gland Biology and Neoplasia.

[30]  Alan Mackay,et al.  Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. , 2004, Cancer research.

[31]  S. Lemeshow,et al.  Genetic model of multi-step breast carcinogenesis involving the epithelium and stroma: clues to tumour-microenvironment interactions. , 2001, Human molecular genetics.

[32]  Sanford H Barsky,et al.  Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype. , 2003, Experimental and molecular pathology.

[33]  L. Cupples,et al.  Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomas. , 2002, The American journal of pathology.

[34]  V. Steele,et al.  Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer. , 2003, Mutation research.

[35]  B. Unsworth,et al.  Breast Cancer: Induction of Differentiation by Embryonic Tissue , 1973, Science.

[36]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[37]  Mina J Bissell,et al.  Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. , 2010, Journal of cell science.

[38]  Ana M Soto,et al.  The stroma as a crucial target in rat mammary gland carcinogenesis , 2004, Journal of Cell Science.

[39]  T. Tlsty,et al.  Stromal cells can contribute oncogenic signals. , 2001, Seminars in cancer biology.

[40]  M. Shekhar,et al.  Host microenvironment in breast cancer development: Extracellular matrix–stromal cell contribution to neoplastic phenotype of epithelial cells in the breast , 2003, Breast Cancer Research.

[41]  Z. Shao,et al.  The human myoepithelial cell is a natural tumor suppressor. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[42]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[43]  J. Tobacman Filament Disassembly and Loss of Mammary Myoepithelial Cells after Exposure to λ-Carrageenan , 1997 .

[44]  A. Gerdes,et al.  Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue , 1995, International journal of cancer.

[45]  P. Sommer,et al.  Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma. , 1997, The American journal of pathology.

[46]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[47]  L. Gaboury,et al.  Basal Cells of Second Trimester Fetal Breasts: Immunohistochemical Study of Myoepithelial Precursors , 2003, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[48]  Martin A. Nowak,et al.  The significance of unstable chromosomes in colorectal cancer , 2003, Nature Reviews Cancer.

[49]  S. Barsky,et al.  The myoepithelial defense: a host defense against cancer. , 1997, Medical hypotheses.

[50]  Dennis C. Sgroi,et al.  Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion , 2005, Cell.

[51]  C. Morrison,et al.  Combined Total Genome Loss of Heterozygosity Scan of Breast Cancer Stroma and Epithelium Reveals Multiplicity of Stromal Targets , 2004, Cancer Research.

[52]  R. Shore,et al.  The risk of breast cancer after irradiation of the thymus in infancy. , 1989, The New England journal of medicine.

[53]  M. Stratton,et al.  Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. , 1998, Journal of the National Cancer Institute.

[54]  S. Swain,et al.  Ductal carcinoma in situ, complexities and challenges. , 2004, Journal of the National Cancer Institute.

[55]  Mina J Bissell,et al.  The organizing principle: microenvironmental influences in the normal and malignant breast. , 2002, Differentiation; research in biological diversity.

[56]  K. Malone,et al.  Age-Specific Incidence Rates of In situ Breast Carcinomas by Histologic Type, 1980 to 2001 , 2005, Cancer Epidemiology Biomarkers & Prevention.

[57]  F. Miller Xenograft Models of Premalignant Breast Disease , 2000, Journal of Mammary Gland Biology and Neoplasia.

[58]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[59]  F. Miller,et al.  MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ. , 2000, Journal of the National Cancer Institute.

[60]  J. Varley,et al.  Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma , 1997, Oncogene.

[61]  F. Kittrell,et al.  Stroma is not a major target in DMBA-mediated tumorigenesis of mouse mammary preneoplasia , 2005, Journal of Cell Science.

[62]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[63]  T. Ushijima,et al.  Detection and interpretation of altered methylation patterns in cancer cells , 2005, Nature Reviews Cancer.

[64]  Mina J Bissell,et al.  Tumor reversion: Correction of malignant behavior by microenvironmental cues , 2003, International journal of cancer.

[65]  D. Trichopoulos Intrauterine environment, mammary gland mass and breast cancer risk , 2002, Breast Cancer Research.

[66]  J. Tobacman Filament disassembly and loss of mammary myoepithelial cells after exposure to lambda-carrageenan. , 1997, Cancer research.

[67]  K. Hunter,et al.  Host genetics and tumour metastasis , 2004, British Journal of Cancer.

[68]  T. Hunt,et al.  Multiple Organ Engraftment by Bone‐Marrow‐Derived Myofibroblasts and Fibroblasts in Bone‐Marrow‐Transplanted Mice , 2003, Stem cells.

[69]  S. Lakhani,et al.  Molecular evolution of breast cancer , 2005, The Journal of pathology.

[70]  Jun Yao,et al.  Distinct epigenetic changes in the stromal cells of breast cancers , 2005, Nature Genetics.

[71]  M. Washington,et al.  TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia , 2004, Science.

[72]  M. Bissell,et al.  The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. , 1995, The Journal of clinical investigation.

[73]  G. Felsenfeld,et al.  Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene , 2000, Nature.

[74]  S. Barsky,et al.  Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms. , 2000, Cancer letters.

[75]  Holly Dressman,et al.  Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction. , 2003, Human molecular genetics.

[76]  S. Hayward,et al.  Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. , 2005, Oncogene.

[77]  J. Marks,et al.  A SAGE (serial analysis of gene expression) view of breast tumor progression. , 2001, Cancer research.

[78]  R. Poulsom,et al.  Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon , 2002, Gut.

[79]  Generoso Bevilacqua,et al.  Bio-morphological events in the development of the human female mammary gland from fetal age to puberty , 2000, Virchows Archiv.

[80]  S. Hayward,et al.  Loss of TGF-β type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-α-, MSP- and HGF-mediated signaling networks , 2005, Oncogene.

[81]  Sushanta K Banerjee,et al.  Neuropilin‐1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: A possible marker for the progression of breast cancer , 2002, International journal of cancer.

[82]  L. Kiemeney,et al.  High prevalence of premalignant lesions in prophylactically removed breasts from women at hereditary risk for breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[83]  C. Foster,et al.  Molecular and genetic abnormalities in radial scar. , 2002, Human pathology.

[84]  Satoshi Matsumoto,et al.  Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas , 2002, Nature Genetics.

[85]  D. Santini,et al.  Immunocytochemical Expression of Epidermal Growth Factor Receptor in Myoepithelial Cells of the Breast , 2002, Applied immunohistochemistry & molecular morphology : AIMM.

[86]  M J Bissell,et al.  Tumors are unique organs defined by abnormal signaling and context. , 2001, Seminars in cancer biology.

[87]  J. Thiery,et al.  The importance of being a myoepithelial cell , 2002, Breast Cancer Research.

[88]  P. Goss,et al.  Breast cancer risk following irradiation for Hodgkin's disease. , 2000, Cancer treatment reviews.

[89]  S. Lakhani,et al.  The mammary myoepithelial cell - Cinderella or ugly sister? , 2000, Breast Cancer Research.

[90]  Zena Werb,et al.  Stromal Effects on Mammary Gland Development and Breast Cancer , 2002, Science.

[91]  M J O'Hare,et al.  Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[92]  R. Weinberg,et al.  Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. , 2001, Experimental cell research.

[93]  G. Dontu,et al.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.

[94]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[95]  A. Thor,et al.  Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas , 1996, Science.

[96]  Russell Vang,et al.  Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion , 2003, Breast Cancer Research.

[97]  S. Love,et al.  ‘Revertant’ DCIS in human axillary breast carcinoma metastases , 1997, The Journal of pathology.

[98]  J. Shaw,et al.  Primary breast myoepithelial cells exert an invasion‐suppressor effect on breast cancer cells via paracrine down‐regulation of MMP expression in fibroblasts and tumour cells , 2003, The Journal of pathology.

[99]  A. Gown,et al.  Myoepithelial cells and basal lamina in poorly differentiated in situ duct carcinoma of the breast , 1999, Virchows Archiv.

[100]  Z. Shao,et al.  The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1/CIP1 induction, G2/M arrest, and apoptosis. , 1998, Experimental cell research.